Making moves to Notting Hill

New lab? Yes please!

We are very excited to officially announce that Diag-Nose has moved into a new cutting-edge laboratory facility at CoLabs Notting Hill. It’s bigger and better, drastically increasing our capacity to innovatory experiments in biomarker discovery, assay development and validation, and marks a significant milestone in company growth.

‍

Cross-collaboration & state-of-the-art infrastructure - the new lab has it all

CoLabs is a shared workspace, promoting collaboration and providing state-of-the-art infrastructure. This fosters collaboration within and between leading BioTech and medtech startups, providing access to unique skillsets, backgrounds and technology in an innovatory hub.

Other benefits:

• Ability to refine and scale diagnostic technologies.
• Access to specialised equipment.
• A collaborative environment to engage with industry leads.
• Proximity to existing collaborators at Monash Health and Monash University.

This move strengthens our ability to develop next-generation diagnostic solutions and positions us at the forefront of biomarker-driven precision medicine.

‍

Unlocking the future of clinical applications

Our new facility is equipped to accelerate our RhinoMAP biomarker platform and optimise the ABEL nasal microsampler. Now more than ever we have the ability to streamline the transition from research, to real-world clinical applications.

‍

What’s next for Diag-Nose?

With our new lab operational, we will scale up biomarker research, optimize assay development, and advance our clinical validation pipeline. Our team will also be expanding collaborations with industry partners, researchers, and clinicians to accelerate the adoption of nasal fluid diagnostics in respiratory care.

‍

Keep an eye out for our latest breakthrough and behind-the scenes updates by following us on LinkedIn!

‍